Home Healthcare IT Advanced Therapy Medicinal Products (ATMP) Market Size and Growth | Industry Report by 203

Advanced Therapy Medicinal Products (ATMP) Market Size, Share & Trends Analysis Report By Therapy Type (Cell Therapy, Gene Therapy, CAR-T Therapy, Tissue Engineered Products), By Manufacturer (Biopharmaceutical Companies, Contract Development and Manufacturing Organizations (CDMOs), Digital Platform Providers) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Report Code: SRHI54723DR
Last Updated: Mar, 2026
Pages: 150
Author: Debashree Bora
Format: PDF, Excel

Table Of Content

  1. Executive Summary
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
    1. Drivers
    2. Market Warning Factors
    3. Latest Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
    1. North America
    2. Europe
    3. APAC
    4. Middle East and Africa
    5. LATAM
  2. ESG Trends
    1. Global Advanced Therapy Medicinal Products (ATMP) Market Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Digital Platform Providers
        1. By Value
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Digital Platform Providers
        1. By Value
    4. U.S.
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
        3. Gene Therapy
          1. By Value
        4. CAR-T Therapy
          1. By Value
        5. Tissue Engineered Products
          1. By Value
      2. By Manufacturer
        1. Introduction
          1. Manufacturer By Value
        2. Biopharmaceutical Companies
          1. By Value
        3. Contract Development and Manufacturing Organizations (CDMOs)
          1. By Value
        4. Digital Platform Providers
          1. By Value
    5. Canada
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Digital Platform Providers
        1. By Value
    4. U.K.
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
        3. Gene Therapy
          1. By Value
        4. CAR-T Therapy
          1. By Value
        5. Tissue Engineered Products
          1. By Value
      2. By Manufacturer
        1. Introduction
          1. Manufacturer By Value
        2. Biopharmaceutical Companies
          1. By Value
        3. Contract Development and Manufacturing Organizations (CDMOs)
          1. By Value
        4. Digital Platform Providers
          1. By Value
    5. Germany
    6. France
    7. Spain
    8. Italy
    9. Russia
    10. Nordic
    11. Benelux
    12. Rest of Europe
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Digital Platform Providers
        1. By Value
    4. China
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
        3. Gene Therapy
          1. By Value
        4. CAR-T Therapy
          1. By Value
        5. Tissue Engineered Products
          1. By Value
      2. By Manufacturer
        1. Introduction
          1. Manufacturer By Value
        2. Biopharmaceutical Companies
          1. By Value
        3. Contract Development and Manufacturing Organizations (CDMOs)
          1. By Value
        4. Digital Platform Providers
          1. By Value
    5. Korea
    6. Japan
    7. India
    8. Australia
    9. Singapore
    10. Taiwan
    11. South East Asia
    12. Rest of Asia-Pacific
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Digital Platform Providers
        1. By Value
    4. UAE
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
        3. Gene Therapy
          1. By Value
        4. CAR-T Therapy
          1. By Value
        5. Tissue Engineered Products
          1. By Value
      2. By Manufacturer
        1. Introduction
          1. Manufacturer By Value
        2. Biopharmaceutical Companies
          1. By Value
        3. Contract Development and Manufacturing Organizations (CDMOs)
          1. By Value
        4. Digital Platform Providers
          1. By Value
    5. Turkey
    6. Saudi Arabia
    7. South Africa
    8. Egypt
    9. Nigeria
    10. Rest of MEA
    1. Introduction
    2. By Therapy Type
      1. Introduction
        1. Therapy Type By Value
      2. Cell Therapy
        1. By Value
      3. Gene Therapy
        1. By Value
      4. CAR-T Therapy
        1. By Value
      5. Tissue Engineered Products
        1. By Value
    3. By Manufacturer
      1. Introduction
        1. Manufacturer By Value
      2. Biopharmaceutical Companies
        1. By Value
      3. Contract Development and Manufacturing Organizations (CDMOs)
        1. By Value
      4. Digital Platform Providers
        1. By Value
    4. Brazil
      1. By Therapy Type
        1. Introduction
          1. Therapy Type By Value
        2. Cell Therapy
          1. By Value
        3. Gene Therapy
          1. By Value
        4. CAR-T Therapy
          1. By Value
        5. Tissue Engineered Products
          1. By Value
      2. By Manufacturer
        1. Introduction
          1. Manufacturer By Value
        2. Biopharmaceutical Companies
          1. By Value
        3. Contract Development and Manufacturing Organizations (CDMOs)
          1. By Value
        4. Digital Platform Providers
          1. By Value
    5. Mexico
    6. Argentina
    7. Chile
    8. Colombia
    9. Rest of LATAM
    1. Advanced Therapy Medicinal Products (ATMP) Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    1. Novartis AG
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Gilead Sciences, Inc.
    3. Bristol Myers Squibb
    4. bluebird bio, Inc.
    5. Bayer AG (AskBio)
    6. Spark Therapeutics (Roche)
    7. Adaptimmune
    8. CRISPR Therapeutics AG
    9. JCR Pharmaceuticals Co., Ltd.
    10. Kolon TissueGene, Inc.
    11. Vericel Corporation
    12. Pfizer Inc.
    13. BBG Advanced Therapies (BBGAT)
    14. A-SEEDS Co. Ltd.
    15. Eli Lilly
    16. Bharat Biotech
    17. Medigene AG
    18. UniQure N.V.
    19. SCTbio
    20. FUJIFILM Biotechnologies
    1. Research Data
      1. Secondary Data
        1. Major secondary sources
        2. Key data from secondary sources
      2. Primary Data
        1. Key data from primary sources
        2. Breakdown of primaries
      3. Secondary And Primary Research
        1. Key industry insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
    1. Discussion Guide
    2. Customization Options
    3. Related Reports
  3. Disclaimer
Get This Report

Download Free Sample

Our Clients:

LG Electronics
AMCAD Engineering
KOBE STEEL LTD.
Hindustan National Glass & Industries Limited
Voith Group
International Paper
Hansol Paper
Whirlpool Corporation
Sony
Samsung Electronics
Qualcomm
Google
Fiserv
Veto-Pharma
Nippon Becton Dickinson
Merck
Argon Medical Devices
Abbott
Ajinomoto
Denon
Doosan
Meiji Seika Kaisha Ltd
LG Chemicals
LCY chemical group
Bayer
Airrane
BASF
Toyota Industries
Nissan Motors
Neenah
Mitsubishi
Hyundai Motor Company

We are featured on:

WhatsApp
Chat with us on WhatsApp
Straits Research
Address:
Office 515 A, Amanora Chambers,
Amanora Park Town, Hadapsar,
Pune 411028, Maharashtra, India.
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.